201217-moderna-vaccine-jm-1203_0b6cf9ac5ce534690923d0236ed1cd07.jpg

  • December 20, 2020
  • 0
  • 3 Views

FILE – In this March 16, 2020, file photo, Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The vaccine by Cambridge, Massachusetts-based Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in a study of volunteers who were given either a low or medium dose. (AP Photo/Ted S. Warren, File)


Upstate News Headlines

PHP Code Snippets Powered By : XYZScripts.com
X